Skip to content
NBDC Human Database

No datasets in the cart.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Research list

TSV

Refine

Sort by
Date modified
Per page
20

1–20 / 411

CartResearch IDDataset IDResearch titleAnalysis methodType of dataPlatformsParticipantsAccess criteriaData providerDate publishedDate modified
hum0611
Analysis of Protein and Gene Expression in Blood Cells from Patients with Hematologic Disorders
Expression profiling
NGS
(RNA-seq)
  • Illumina NovaSeq 6000
  • Illumina NovaSeq X Plus
cGVHD: 4 cases
hematologic disorders (controls): 3 cases
(Japanese)
  • Controlled-access (Type I)
  • Koji Jimbo
2026-11-102026-11-10
hum0231
A study for the establishment of disease-specific iPS cells.
Sequencing
Expression profiling
Histone modification
NGS
(Exome, RNA-seq, ChIP-seq)
  • Illumina HiSeq 2500
  • Illumina NextSeq 500
120 + 2 Healthy volunteers
(Japanese)
  • Controlled-access (Type I)
  • Megumu K. Saito
2024-07-222026-11-06
hum0257
Development of culturing methods amplifying micro-specimens derived from human pancreas and biliary tract tissues
Sequencing, Expression profiling, Chromatin structure profiling, Histone modification profiling
NGS
(Exome, RNA-seq, ATAC-seq, ChIP-seq, Hi-C)
  • Illumina HiSeq 2500
  • Illumina NextSeq 500
  • Illumina NovaSeq 6000
  • Oxford Nanopore Technologies MinION
Pancreatic ductal adenocarcinoma: 17 cases
Intraductal papillary mucinous neoplasm (IPMN): 6+3 cases
Pancreatic cancer: 11 cases
IPMN-derived pancreatic cancers: 2 cases
Non-tumor pancreatic tissue: 1 case
(Japanese)
  • Unrestricted-access
  • Controlled-access (Type I)
  • Keisuke Tateishi (Genome Science)
2021-12-242026-11-04
hum0574
Research on constructing a genome analysis database for malignant tumors
Sequencing, Expression profiling
NGS
(Exome, RNA-seq, WGS)
  • Illumina NovaSeq 6000
rectal cancer: 2 cases
gastric adenocarcinoma: 4 cases
colorectal cancer: 32 cases
(Japanese)
  • Controlled-access (Type I)
  • Yoshifumi Shimada
2026-07-242026-11-04
hum0294
Single cell analysis of tumor-infiltrating T cells
Sequencing, Expression profiling
NGS
(Exome, RNA-seq, scRNA-seq, scTCR-seq)
  • Illumina HiSeq X
  • Illumina NovaSeq X Plus
esophageal cancer: 28 cases
gastric cancer: 12 cases
gastroesophageal junction cancer: 2 cases
(Japanese)
  • Controlled-access (Type I)
  • Shogo Kumagai
2024-05-292026-11-02
hum0612
Registered research projects for new genetic test analysis data in the restricted-access database
Sequencing
NGS (Targeted DNA-seq, Targeted RNA-seq)
  • Illumina MiSeq
xeroderma pigmentosum: 1 case
(Japanese)
  • Controlled-access (Type I)
  • Yo Niida
2026-10-282026-10-28
hum0489
Genetic Mutation Spectrum Analysis in Bone and Soft Tissue Sarcomas
Sequencing,
Expression profiling
NGS (Exome, RNA-seq)
  • Illumina HiSeq 2500
  • Illumina NovaSeq X Plus
  • MGI DNBSEQ-G400
myxoid liposarcoma: 72cases
(Japanese)
ヒト粘液型脂肪肉腫細胞株: 3 samples
(Cell-line)
  • Controlled-access (Type I)
  • Koji Ueda
2026-10-272026-10-27
hum0615
Genomic Analysis of Digestive System Malignancies and Precancerous Lesions
Sequencing
NGS (Exome)
  • Illumina NovaSeq X Plus
IPNB: 10 cases
(Japanese)
  • Controlled-access (Type I)
  • Takamichi Ishii
2026-10-232026-10-23
hum0030
The Molecular Biological Analysis about Occurrence and Malignant Transformation in gynecological carcinogenesis
Genome-wide CNV analysis, sequencing, expression profiling, methylation profiling
SNP-chip, NGS (Exome, RNA-seq, Target bisulfite-seq), Methylation array, Expression array, Xenium In Situ Gene Expression
  • 10x Genomics Xenium Analyzer
  • Affymetrix GeneChip Human Genome U133 Plus 2.0 Array
  • Affymetrix GeneChip Human Mapping 250K Nsp Array
57 + 111 + 31 + 189 Ovarian carcinomas
86 Endometrial cancers
8 Uterine carcinosarcomas
(Japanese)
  • Controlled-access (Type I)
  • Katsutoshi Oda (P-DIRECT)
2015-04-212026-10-22
hum0553
Study of anti-malignant cancer drug target using human CRC patient samples
Sequencing,
Expression profiling
NGS
(Exome, RNA-seq)
  • Illumina NovaSeq 6000
colorectal cancer: 1 case
(Japanese)
  • Controlled-access (Type I)
  • Masanobu Oshima
2026-10-142026-10-14
hum0606
A Basic Investigation of Factors Affecting the Analytical Performance of Whole-Genome Sequencing and Related Analyses Using Tissue Specimens from Patients with Solid Tumors
Sequencing, Expression profiling
NGS
(WGS, RNA-seq)
  • Illumina NovaSeq 6000
Endometrial cancer: 1 case
(Japanese)
Breast cancer cell line-derived xenograft: 1 model
(Cell line)
  • Controlled-access (Type I)
  • Yutaka Hatanaka
2026-10-142026-10-14
hum0455
Explore genetic abnormalities, molecular targets, predictive of drug sensitivity, histomorphology, and biomarkers in lung cancer / Analysis of genetic abnormalities and their biological significance in lung cancer
Sequencing; Expression profiling;
NGS (WGS, Visium Spatial Gene Expression, snRNA-seq, STOmics); Xenium In Situ Gene Expression; Histological image; Spatial Proteomics
  • 10x Genomics Xenium Analyzer
  • Akoya Biosciences PhenoCycler
  • Illumina NovaSeq 6000
pulmonary neuroendocrine carcinoma: 10+ 10 + 13 cases
(Japanese)
  • Controlled-access (Type I)
  • Daisuke Matsubara
2025-08-042026-10-09
hum0335
Research on new diagnosis and clinical picture of lymphoproliferative diseases by combining genetic analysis and immunological traits
Sequencing
NGS
(Target Capture, Exome)
  • Illumina NextSeq 500
  • Illumina NovaSeq 6000
Waldenström macroglobulinemia: 10 cases
non IgM-type lymphoplasmacytic lymphoma: 10 cases
T cell lymphoproliferative disease: 1 case
(Japanese)
  • Unrestricted-access
  • Controlled-access (Type I)
  • Akihiko Yokohama
2022-09-142026-10-01
hum0607
Exploratory Biomarker Study Associated with the Investigator-Initiated Clinical Trial of Alectinib for Rare Cancers Harboring ALK Alterations
Sequencing
NGS
(Target capture)
  • Illumina NovaSeq 6000
Rare cancers harboring ALK alterations: 24 cases
(Japanese)
  • Controlled-access (Type I)
  • Shinji Kohsaka
2026-10-012026-10-01
hum0511
Identification of Molecular Markers and Elucidation of Molecular Mechanisms in Aging Using Centenarian Samples
Expression profiling
NGS
(scRNA-seq, scTCR-seq, scCITE-seq, bulk RNA-seq)
  • Illumina NovaSeq X
  • MGI DNBSEQ-G400
28 healthy individuals
(Japanese)
  • Unrestricted-access
  • Controlled-access (Type I)
  • Kosuke Hashimoto
2026-07-302026-09-18
hum0567
The mutiomics analysis on liver tumor with rare liver diseases, including Fontan associated liver diseases
Sequencing; Expression profiling
NGS
(WGS, RNA-seq)
  • Illumina NovaSeq 6000
  • Illumina NovaSeq X Plus
liver cancer caused by rare liver diseases: 13 cases
(Japanese)
  • Controlled-access (Type I)
  • Tatsuya Kanto
2026-09-182026-09-18
hum0600
Elucidation of the Molecular Mechanisms of Advanced Thyroid Cancer through Single-Cell Gene Expression Analysis
Expression profiling
NGS
(scRNA-seq)
  • Illumina HiSeq X
undifferentiated thyroid carcinoma: 3 cases
papillary thyroid carcinoma: 3 cases
(Japanese)
  • Unrestricted-access
  • Controlled-access (Type I)
  • Akiko Iguchi
2026-09-172026-09-17
hum0513
Immune profiling study of COVID-19 vaccine recipients
Expression profiling
NGS
(scRNA-seq, scTCR-seq)
  • MGI DNBSEQ-G400
14 healthy donors who received COVID-19 vaccines
(Japanese)
  • Controlled-access (Type I)
  • Yoshimasa Takahashi
2026-09-082026-09-08
hum0585
Derivation of human post-mitotic cardiomyocytes from tetraploid iPSCs
Expression profiling
NGS
(RNA-seq)
  • MGI DNBSEQ-G400
undifferentiated iPS cells and differentiated cardiomyocytes: 12 samples
(Cell-line)
  • Unrestricted-access
  • Yuichiro Miyaoka
2026-08-282026-08-28
hum0358
Research of genetic abnormalities related to the development and prognosis of adenocarcinoma and squamous cell carcinoma of the cervix and vaginal and vulvar cancer
Sequencing, Expression profiling, Methylation profiling
NGS (Exome, RNA-seq, scRNA-seq, Target bisulfite-seq); Xenium In Situ Gene Expression
  • 10x Genomics Xenium Analyzer
  • Illumina MiSeq
  • Illumina NovaSeq 6000
  • Illumina NovaSeq X Plus
cervical cancer: 19 + 4 + 96 cases
(Japanese)
NIKS18 cell line: 5 samples
(Cell-line)
  • Controlled-access (Type I)
  • Kenbun Sone
2022-12-202026-08-20

1–20 / 411